欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
2858	Mometasone furoate monohydrate, Micronised	CIPLA LIMITED Mumbai IN	100006004;100018147	CEP 2018-290 - Rev 02	2025/06/18	Valid		Chemical	2025/06/18	Minor revision\|CEP granted\|18/06/2025; Renewal\|CEP granted\|23/01/2025
1346	Metamizole sodium monohydrate	HEBEI JIHENG PHARMACEUTICAL CO., LTD. Hengshui City CN	100016565;100052147	CEP 2005-143 - Rev 03	2025/06/18	Valid		Chemical	2025/06/18	Minor revision\|CEP granted\|18/06/2025; Minor revision\|CEP granted\|03/03/2021
2732	Dienogest	STERLING S.p.A. Solomeo Di Corciano IT	100024377;100033551	CEP 2016-158 - Rev 01	2025/06/18	Valid		Chemical	2025/06/18	Major revision\|CEP granted\|18/06/2025; Renewal\|CEP granted\|02/08/2023
2762	Capecitabine	SHILPA PHARMA LIFESCIENCES LIMITED Raichur IN	100044578;100073706	CEP 2014-332 - Rev 03	2025/06/18	Valid		Chemical	2025/06/18	Minor revision\|CEP granted\|18/06/2025; Notification\|Accepted - CEP remains valid\|26/10/2023; Minor revision\|CEP granted\|07/02/2023; Notification\|CEP granted\|20/07/2022; Renewal\|CEP granted\|30/09/2021; Minor revision\|Accepted - CEP remains valid\|30/07/2020
464	Amitriptyline hydrochloride	MANKIND PHARMA LIMITED New Delhi IN	100040218;100065486	CEP 2019-227 - Rev 01	2025/06/18	Valid	16/07/2026	Chemical	2025/06/18	Notification\|CEP granted\|18/06/2025
2856	Pirfenidone	MICRO LABS LIMITED Bengaluru IN	100017819;100077269	CEP 2019-155 - Rev 02	2025/06/18	Valid		Chemical	2025/06/18	Renewal\|CEP granted\|18/06/2025; Minor revision\|CEP granted\|16/11/2022
2296	Pantoprazole sodium sesquihydrate	MANKIND PHARMA LIMITED New Delhi IN	100040218;100065486	CEP 2021-073 - Rev 01	2025/06/18	Valid	14/11/2027	Chemical	2025/06/18	Notification\|CEP granted\|18/06/2025; New application\|CEP granted\|14/11/2022
2358	Teicoplanin, Process II	LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Fuzhou CN	100020920;100029633	CEP 2025-047 - Rev 00	2025/06/18	Valid	18/06/2030	Chemical	2025/06/18	New application\|CEP granted\|18/06/2025
272	Doxycycline hyclate, Process Ⅱ	SHANDONG GUOBANG PHARMACEUTICAL CO., LTD. Weifang CN	100036834;100058198	CEP 2025-191 - Rev 00	2025/06/18	Valid	18/06/2030	Chemical	2025/06/18	New application\|CEP granted\|18/06/2025
2404	Drospirenone, Code 202900	STERLING CHEMICAL MALTA LTD. Birzebbugia MT	100021162;100039059	CEP 2023-457 - Rev 00	2025/06/18	Valid	18/06/2030	Chemical	2025/06/18	New application\|CEP granted\|18/06/2025
2307	Modafinil	SYMED LABS LIMITED Hyderabad IN	100018727;100053490	CEP 2024-098 - Rev 00	2025/06/18	Valid	18/06/2030	Chemical	2025/06/18	New application\|CEP granted\|18/06/2025
2284	Calcipotriol monohydrate	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2014-016 - Rev 02	2025/06/17	Valid		Chemical	2025/06/17	Notification\|CEP granted\|17/06/2025; Notification\|CEP granted\|20/12/2021
698	Warfarin sodium	CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad IN	100053345;100094249	CEP 2008-321 - Rev 02	2025/06/17	Valid		Chemical	2025/06/17	Notification\|CEP granted\|17/06/2025
57	Tetracaine hydrochloride	CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad IN	100053345;100094249	CEP 2010-256 - Rev 02	2025/06/17	Valid		Chemical	2025/06/17	Notification\|CEP granted\|17/06/2025; Monograph revision\|Accepted - CEP remains valid\|20/04/2022
2541	Quetiapine Fumarate, Process-II	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2023-005 - Rev 02	2025/06/17	Valid	12/12/2028	Chemical	2025/06/17	Minor revision\|CEP granted\|17/06/2025; Notification\|Rejected\|15/05/2025; Notification\|CEP granted\|12/04/2024; New application\|CEP granted\|12/12/2023
253	Ascorbic acid	NORTHEAST PHARMACEUTICAL GROUP CO. LTD Shenyang CN	100021339;100054155	CEP 2022-066 - Rev 01	2025/06/17	Valid	14/06/2029	Chemical	2025/06/17	Notification\|CEP granted\|17/06/2025; New application\|CEP granted\|14/06/2024
699	Warfarin sodium clathrate	CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad IN	100053345;100094249	CEP 2021-450 - Rev 01	2025/06/17	Valid	05/02/2029	Chemical	2025/06/17	Notification\|CEP granted\|17/06/2025; New application\|CEP granted\|05/02/2024
2054	Clofazimine, Triclinic form	MIDAS PHARMA GMBH Ingelheim am Rhein DE	100001328;100004656	CEP 2019-257 - Rev 02	2025/06/17	Valid	15/10/2026	Chemical	2025/06/17	Minor revision\|CEP granted\|17/06/2025; Notification\|CEP granted\|27/01/2023; Minor revision\|Accepted - CEP remains valid\|16/02/2022
2778	Sitagliptin phosphate monohydrate, 1567	MACLEODS PHARMACEUTICALS LIMITED Mumbai IN	100021441;100077265	CEP 2024-229 - Rev 01	2025/06/17	Valid	10/04/2030	Chemical	2025/06/17	Minor revision\|CEP granted\|17/06/2025; New application\|CEP granted\|10/04/2025
922	Ketoprofen	SNJ LIFECARE PRIVATE LIMITED 363 650 IN	100051847;100091285	CEP 2024-281 - Rev 00	2025/06/17	Valid	17/06/2030	Chemical	2025/06/17	New application\|CEP granted\|17/06/2025

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-